Published in Health and Medicine Week, December 19th, 2005
Under the new program, the company is authorized to repurchase up to $200 million of the company's common stock. The repurchases will be made through open market purchases or private transactions that will be made from time to time as market conditions allow.
The new program is expected to be in effect for a maximum of 4 years. Shares repurchased under the new program will be held in the company's treasury and will be available for a variety of corporate purposes....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health and Medicine Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.